GOLDMAN SACHS GROUP INC - NUVATION BIO INC ownership

NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 74 filers reported holding NUVATION BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NUVATION BIO INC
ValueSharesWeighting
Q3 2023$552,821
-38.8%
412,553
-17.7%
0.00%
Q2 2023$902,694
+36.6%
501,497
+26.0%
0.00%
Q1 2023$660,914
+42.7%
398,141
+65.1%
0.00%
Q4 2022$463,008
-62.0%
241,150
-55.7%
0.00%
Q3 2022$1,220,000
+159.6%
544,347
+275.3%
0.00%
Q2 2022$470,000
-87.5%
145,046
-79.8%
0.00%
-100.0%
Q1 2022$3,769,000
+202.0%
716,445
+387.9%
0.00%
Q4 2021$1,248,000
+129.0%
146,848
+168.1%
0.00%
Q3 2021$545,000
-63.7%
54,773
-66.0%
0.00%
Q2 2021$1,502,000
-34.8%
161,329
-26.8%
0.00%
-100.0%
Q1 2021$2,302,000220,2930.00%
Other shareholders
NUVATION BIO INC shareholders Q1 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 15,072,340$28,938,8939.75%
Aisling Capital Management LP 2,541,009$4,878,7373.22%
EDBI Pte Ltd 1,270,504$2,439,3683.11%
EcoR1 Capital, LLC 13,896,543$26,681,3630.81%
Deep Track Capital, LP 8,221,188$15,784,6810.66%
AlphaCentric Advisors LLC 325,000$624,0000.62%
683 Capital Management, LLC 2,500,000$4,799,9990.41%
BRAIDWELL LP 4,122,900$7,915,9680.26%
Abrams Capital Management 3,811,513$7,318,1050.26%
Redmile Group, LLC 3,031,009$5,819,5370.24%
View complete list of NUVATION BIO INC shareholders